All In MedTech

Company

ResMed

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

ResMed is on our public-company list (ticker RMD). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

RMD

NYSE · RESMED INC

Public float

$34.9B

Value of shares held by non-insiders on Dec 31, 2025

Revenue

$5.65B

Fiscal year ending Jun 30, 2026

Net income

$1.52B

Fiscal year ending Jun 30, 2026

R&D spending

$378M

Fiscal year ending Jun 30, 2026

Cash

$1.01B

As of Sep 30, 2026

Long-term debt

$250M

As of Sep 30, 2026

Shares outstanding

140.7M

As of Oct 26, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2026–$74.5M––
2025–$74.4M––
2024–$53.1M$105M–
2023–$49.1M$1.07B–
2022–$47.4M$288M–
2021–$37.8M$90.0M–

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For ResMed we have 3 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

The 8 newest of 33 since 2015.

Search the Clearance Tracker

30 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT07785310 · 10 participants (planned) · Start Jan 1, 2027 · Primary completion Sep 1, 2027

    Device: APL Device · For: Obstructive Sleep Apnea

  • NCT07485582 · 90 participants (planned) · Start Sep 2026 · Primary completion Oct 2026

    Device: Device A; Device B and 3 more · For: Obstructive Sleep Apnea

    Sites: Adelaide, Australia; Woodville South, Australia; Perth, Australia · 5 sites in all

  • NCT02811588 · 169 participants · Start Jul 2016 · Primary completion Dec 2024

    Device: Non-invasive ventilation · For: Chronic Obstructive Pulmonary Disease

    Sites: Aachen, Germany; Münster, Germany; Soest, Germany · 4 sites in all

81 more trials with a free account

Reports received

991

Received Nov 1, 2025 to Nov 20, 2026. Includes 6 of another or unstated type.

Malfunction reports

883

89% of reports

Injury reports

84

8.5% of reports

Death reports

18

1.8% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2390700
Jan 24491500
Feb 24881121
Mar 24681400
Apr 24481200
May 24591711
Jun 2488300
Jul 2479220
Aug 24991250
Sep 2465700
Oct 24821103
Nov 2483800
Dec 2459501
Jan 2563600
Feb 2545200
Mar 2586200
Apr 25451100
May 2557400
Jun 25361300
Jul 2592800
Aug 2589400
Sep 2567640
Oct 25170740
Nov 2570720
Dec 2556840
Jan 2659440
Feb 26601000
Mar 26731000
Apr 2677300
May 2641700
Jun 2681600
Jul 2691221
Aug 26871365
Sep 26127400
Oct 26611000
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

3 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

11 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.